Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Alcohol Clin Exp Res. 2019 Apr 12;43(5):907–915. doi: 10.1111/acer.14001

Table 3.

Parameter Estimates for Mediation Models

Model Estimate (Std. Err.) p-value
Outcome: Total # of Mini-drinks
 Predictor: Sedation
  ba −0.034 (0.060) 0.578
  bb 1.735 (0.439) <0.001
  bc (direct effect) −0.686 (0.272) 0.014
  bc’ −0.661 (0.255) 0.012
 Predictor: Stimulation
  ba 0.289 (0.056) <0.001
  bb 1.969 (0.537) <0.001
  bc (direct effect) 0.228 (0.348) 0.516
  bc’ −0.280 (0.342) 0.416
Outcome: Latency to 1st Mini-drink
 Predictor: Sedation
  ba −0.034 (0.060) 0.578
  bb −2.700 (1.086) 0.013
  bc (direct effect) 1.780 (0.691) 0.010
  bc’ 1.823 (0.648) 0.005
 Predictor: Stimulation
  ba 0.289 (0.056) <0.001
  bb −3.385 (1.378) 0.014
  bc (direct effect) −0.150 (0.677) 0.825
  bc’ 0.827 (0.747) 0.268
Outcome: Average BrAC
 Predictor: Sedation
  ba −0.034 (0.060) 0.578
  bb 0.018 (0.005) <0.001
  bc (direct effect) −0.006 (0.002) 0.020
  bc’ −0.005 (0.002) 0.011
 Predictor: Stimulation
  ba 0.289 (0.056) <0.001
  bb 0.015 (0.005) 0.002
  bc (direct effect) 0.008 (0.004) 0.028
  bc’ 0.004 (0.003) 0.184

Note: All estimates presented are unstandardized coefficients. The term bc’ represents the effect of the predictor on the outcome while controlling for craving mediator. The term bb represents the effect of the mediator when the predictor is in the models. For latency (seconds) to 1st drink outcome, estimates derived from Accelerated Failure Time (AFT) models, whereas all other outcomes utilized mixed models. In all analyses, the following variables were controlled for: medication, randomization order for medication, OPRM1 status, gender, ethnicity, drinking days past 30 days, drinks per drinking day past 30 days, and alcohol metabolites (ALDH2 (rs671) and ADH1B (rs1229984). Significance status of these covariates is reported within the manuscript.

denotes significant mediated effect of craving